1. Home
  2. WVE vs FMBH Comparison

WVE vs FMBH Comparison

Compare WVE & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • FMBH
  • Stock Information
  • Founded
  • WVE 2012
  • FMBH 1865
  • Country
  • WVE Singapore
  • FMBH United States
  • Employees
  • WVE N/A
  • FMBH N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • FMBH Major Banks
  • Sector
  • WVE Health Care
  • FMBH Finance
  • Exchange
  • WVE Nasdaq
  • FMBH Nasdaq
  • Market Cap
  • WVE 915.6M
  • FMBH 853.8M
  • IPO Year
  • WVE 2015
  • FMBH N/A
  • Fundamental
  • Price
  • WVE $9.76
  • FMBH $37.57
  • Analyst Decision
  • WVE Strong Buy
  • FMBH Hold
  • Analyst Count
  • WVE 16
  • FMBH 5
  • Target Price
  • WVE $20.00
  • FMBH $43.40
  • AVG Volume (30 Days)
  • WVE 1.6M
  • FMBH 61.7K
  • Earning Date
  • WVE 07-30-2025
  • FMBH 07-24-2025
  • Dividend Yield
  • WVE N/A
  • FMBH 2.64%
  • EPS Growth
  • WVE N/A
  • FMBH 13.11
  • EPS
  • WVE N/A
  • FMBH 3.52
  • Revenue
  • WVE $93,946,000.00
  • FMBH $328,480,000.00
  • Revenue This Year
  • WVE N/A
  • FMBH N/A
  • Revenue Next Year
  • WVE $4.55
  • FMBH $4.60
  • P/E Ratio
  • WVE N/A
  • FMBH $10.75
  • Revenue Growth
  • WVE N/A
  • FMBH 7.81
  • 52 Week Low
  • WVE $5.04
  • FMBH $27.58
  • 52 Week High
  • WVE $16.74
  • FMBH $43.86
  • Technical
  • Relative Strength Index (RSI)
  • WVE 72.03
  • FMBH 45.18
  • Support Level
  • WVE $8.40
  • FMBH $37.08
  • Resistance Level
  • WVE $9.03
  • FMBH $39.42
  • Average True Range (ATR)
  • WVE 0.55
  • FMBH 0.95
  • MACD
  • WVE 0.06
  • FMBH -0.02
  • Stochastic Oscillator
  • WVE 98.53
  • FMBH 28.24

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

Share on Social Networks: